PharmaEngine (4162) — Cash Flow Reinvestment Rate
PharmaEngine (4162) has a Cash Flow Reinvestment Rate of 8.59x as of September 2025, reinvesting NT$455.53 Million (capex NT$115.00K plus investments NT$-455.41 Million) from operating cash flow of NT$53.01 Million. Explore PharmaEngine capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaEngine Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for PharmaEngine across 12 annual periods. Also explore balance sheet size of PharmaEngine for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PharmaEngine (2011–2024)
Year-by-year capital reinvestment analysis for PharmaEngine. For live market cap and broader valuation context, see 4162 company net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.25x | NT$116.09 Million | NT$456.73 Million | NT$1.42 Million | ▼ -92.4% |
| 2023 | 3.33x | NT$856.44 Million | NT$256.97 Million | NT$958.00K | ▲ +258.3% |
| 2022 | 0.93x | NT$187.92 Million | NT$202.01 Million | NT$3.94 Million | ▲ +721.8% |
| 2021 | 0.11x | NT$105.23 Million | NT$929.67 Million | NT$229.00K | ▼ -99.6% |
| 2020 | 27.26x | NT$1.77 Billion | NT$64.77 Million | NT$608.00K | ▲ +2267.7% |
| 2019 | 1.15x | NT$18.51 Million | NT$16.08 Million | NT$208.00K | ▲ +42.4% |
| 2018 | 0.81x | NT$602.36 Million | NT$745.23 Million | NT$510.00K | ▲ +8.1% |
| 2016 | 0.75x | NT$650.89 Million | NT$870.38 Million | NT$1.15 Million | ▼ -87.7% |
| 2015 | 6.10x | NT$2.73 Billion | NT$447.99 Million | NT$11.80 Million | ▲ +841249.6% |
| 2014 | 0.00x | NT$95.00K | NT$131.09 Million | NT$95.00K | ▼ -40.1% |
| 2012 | 0.00x | NT$83.00K | NT$68.64 Million | NT$83.00K | ▼ -58.7% |
| 2011 | 0.00x | NT$806.00K | NT$275.49 Million | NT$806.00K | — |